Home » Topics » BioWorld Science

BioWorld Science
RSS

Johnson & Johnson reviews progress of first quarter 2018

April 20, 2018

ADC Therapeutics presents potent antitumoral compounds in xenograft models

April 20, 2018

FDA accepts Veloxis' sNDA for Envarsus XR

April 20, 2018

First-in-human study of FS-118 in advanced solid tumors enrolling subjects

April 20, 2018

Otsuka launches Rexulti in Japan

April 20, 2018

Goofice tablet launched in Japan

April 20, 2018

CD163, VCAM-1 identified as markers of liver injury in autoimmune hepatitis

April 20, 2018

ApolloBio obtains license to Toca 511/Toca FC for greater China region

April 20, 2018

Phase II E4 Relief study of Donesta achieves primary objective

April 20, 2018

FDA grants fast track designation for balixafortide plus eribulin for metastatic breast cancer

April 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...